skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: In vitro cytotoxicity of human recombinant tumor necrosis factor alpha in association with radiotherapy in a human ovarian carcinoma cell line

Journal Article · · Gynecologic Oncology; (USA)
; ; ; ; ;  [1]
  1. Univ. of California Irvine Medical Center, Orange (USA)

It has been speculated that tumor necrosis factor alpha (TNF-alpha) may decrease the cytotoxicity of radiotherapy by increasing the scavenging of toxic superoxide radicals. Because of the possible clinical implications, the cytotoxicity of TNF-alpha in combination with radiotherapy (RT) was compared with that of RT alone in a human ovarian cancer cell line. NIH:OVCAR-3 cells were incubated with TNF-alpha at 10.0, 1.0, 0.1, and 0.01 microgram/ml. Plates were divided into two groups; one received 150 cGy of radiotherapy and the other received no further therapy. Seventy-two hours later, supernatants were aspirated and viable cells were stained with a 1% solution of crystal violet. Survival of cells treated with RT plus TNF-alpha was expressed as a percentage of surviving irradiated controls. Analysis of results revealed minimal additive cell killing effect between TNF-alpha and radiotherapy at all concentrations of tumor necrosis factor, with the greatest difference noted in the group treated with 10 micrograms/ml TNF-alpha. A continued radiotherapy dose-response study with TNF-alpha showed a similar additive, not radioprotective, effect. This may have implication as a potentiator of RT in some human tumors.

OSTI ID:
6791317
Journal Information:
Gynecologic Oncology; (USA), Vol. 38:2; ISSN 0090-8258
Country of Publication:
United States
Language:
English

Similar Records

Proliferative and antiproliferative effects of interferon-gamma and tumor necrosis factor-alpha on cell lines derived from cervical and ovarian malignancies
Journal Article · Sat Dec 01 00:00:00 EST 1990 · American Journal of Obstetrics and Gynecology; (USA) · OSTI ID:6791317

Radiocurability by Targeting Tumor Necrosis Factor-{alpha} Using a Bispecific Antibody in Carcinoembryonic Antigen Transgenic Mice
Journal Article · Thu Nov 15 00:00:00 EST 2007 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:6791317

Human keratinocytes are a source for tumor necrosis factor alpha: Evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light
Journal Article · Sat Dec 01 00:00:00 EST 1990 · Journal of Experimental Medicine; (USA) · OSTI ID:6791317